• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PAH131002E
Device Problems Difficult or Delayed Activation (2577); Activation Failure (3270)
Patient Problem Aneurysm (1708)
Event Date 03/18/2021
Event Type  malfunction  
Manufacturer Narrative
As the device remains implanted, a further investigation of the device cannot be performed.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
It was reported to gore that patient underwent endovascular treatment for a saccular aneurysm in the right common iliac artery with a gore® viabahn® endoprosthesis with propaten bioactive surface (viabahn-device).It was stated that an additional procedure has taken place, namely a right hypogastric artery embolization with coils.It was reported that there were difficulties pulling the deployment line of the viabahn-device (13mm x 100mm).Therefore, an attempt was made to remove the prosthesis through the dryseal 12fr introducer sheath, which was impossible.It was stated that the viabahn-device was released with great difficulties and with several pulls in an unwanted area between the right common iliac artery and the right external iliac artery.Reportedly, the procedure was completed with an additional viabahn-device (13mm x 50mm) which was implanted proximal to the previous one in the correct place.
 
Manufacturer Narrative
Product history review: a review of the manufacturing records indicated the lot met pre-release manufacturing specifications.As the device remains implanted, no further investigation can be performed.With the information provided to gore, this investigation is considered complete, and the cause of the complaint was unable to be determined.According to the instruction for use for the gore® viabahn® endoprosthesis with propaten bioactive surface the following is mentioned: hazards and adverse events device related: complications and adverse events can occur when using any endovascular device.These complications include, but are not limited to: deployment failure and device failure.
 
Manufacturer Narrative
Report # 2017233-2021-01869 is being retracted.After further evaluation, this complaint was deemed not reportable.The device successfully deployed, no reported vessel coverage reported with deployment in an unintended location and no patient harm indicated by the report.The procedure ended successfully with additional device deployment.H1: update to 'other' for report retraction.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11684191
MDR Text Key246016312
Report Number2017233-2021-01869
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeSP
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 07/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/10/2023
Device Catalogue NumberPAH131002E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/22/2021
Initial Date FDA Received04/19/2021
Supplement Dates Manufacturer Received03/15/2022
07/20/2022
Supplement Dates FDA Received04/13/2022
07/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/10/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age87 YR
Patient SexMale
Patient Weight80 KG
-
-